drugset / Trial / NCT05199129
Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate of efficacy and safety of HCP1904-3 and RLD2001-1 alone in patients with essential hypertension inadequately controlled on RLD2001-1 monotherapy.
Timeline
- Start
- 2021-11-17
- Primary completion
- 2022-09-14
- Completion
- 2022-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1904-3 | Unknown | — | Oral |
| Subject | RLD2001-1 | Unknown | — | Oral |